Over the past few months, the COVID-19 pandemic has revealed gaps in the global pharmaceutical supply chain for drugs in clinical trials and for marketed drugs. Drug manufacturing can be a long and complex process requiring specialized expertise. The biopharmaceutical industry realized this and started to outsource the majority of its manufacturing over the past two decades. While a lot of manufacturing still takes place in the United States, United Kingdom and Europe, biopharma companies have increasingly looked to Asia and India for lower cost manufacturing. …

Michelle Dipp

Co-Founder and Managing Partner at Biospring Partners https://www.biospring.com | https://michelle-dipp.com

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store